Next Article in Journal
Predicting Future Prospects of Aptamers in Field-Effect Transistor Biosensors
Next Article in Special Issue
Total Versus Inorganic and Organic Species of As, Cr, and Sb in Flavored and Functional Drinking Waters: Analysis and Risk Assessment
Previous Article in Journal
Biological Activity of Essential Oils
Previous Article in Special Issue
Sensory Lexicons and Formation Pathways of Off-Aromas in Dairy Ingredients: A Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Insoluble-Bound Polyphenols Released from Guarana Powder: Inhibition of Alpha-Glucosidase and Proanthocyanidin Profile

by
Ana Clara da Costa Pinaffi
1,
Geni Rodrigues Sampaio
1,
Maiara Jurema Soares
1,
Fereidoon Shahidi
2,
Adriano Costa de Camargo
3,* and
Elizabeth A. F. S. Torres
1,*
1
School of Public Health, University of Sao Paulo, 715 Dr Arnaldo Avenue, Sao Paulo, Sao Paulo 01246-904, Brazil
2
Department of Biochemistry, Memorial University of Newfoundland, St. John’s, NL A1B 3X9, Canada
3
Departamento de Ciencias Vegetales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad, Católica de Chile, Casilla 306-22, Santiago, Chile
*
Authors to whom correspondence should be addressed.
Molecules 2020, 25(3), 679; https://doi.org/10.3390/molecules25030679
Submission received: 13 January 2020 / Revised: 1 February 2020 / Accepted: 4 February 2020 / Published: 5 February 2020
(This article belongs to the Special Issue Recent Advances in Studies of Food and Beverages II)

Abstract

:
The Brazilian Food Supplement Law recently recognized that guarana (Paullinia cupana) contains bioactive substances, hence supporting its role as a functional food ingredient. The health benefits of guarana are associated, at least in part, to its phenolic compounds. However, to the best of our knowledge, there is no literature addressing the presence of phenolic compounds in the fraction containing insoluble-bound compounds and its contribution in terms of alpha-glucosidase inhibition. The concentration of phenolic extracts released from the insoluble-bound fraction required to inhibit 50% of alpha-glucosidase (IC50) activity was 5.8-fold lower than that present in the soluble counterpart. Both fractions exhibited a mixed inhibition mode. Fourteen proanthocyanidins (dimers to tetramers) present in the insoluble-bound fraction were tentatively identified by MALDi-TOF-MS. Future studies aiming at increasing the concentration of the soluble counterpart are deemed necessary. The results presented here enhance the phenolic database of guarana and have a practical impact on the procurement of nutraceuticals and functional ingredients related to the prevention and/or management of type 2 diabetes. The Brazilian normative on food supplements has been recently revised. This study lends support to the future inclusion of guarana powder in the list of sources of proanthocyanidins for the industry of food supplements.

1. Introduction

Guarana (Paullinia cupana) is a plant deeply rooted in the cultural identity of the Brazilian indigenous population, to whom it is credited the domestication and traditional processing of the plant’s fruit. The guarana-based beverage was consumed as an energy source for hunters and during fishing, and for the treatment of headache and fever [1]. Nowadays, this product of the Amazonian rainforest is known worldwide for its stimulating properties and potential health benefits. Studies have shown health effects related to guarana consumption, such as increased cognitive performance, improved energetic metabolism, lower prevalence of noncommunicable diseases, and improvement of oxidative stress markers [2,3,4,5]. These health effects have mainly been associated with the presence of caffeine and flavanols in guarana’s composition.
The studies of guarana have been focused on the polyphenols extracted with hydro-organic solvents as the representative of the polyphenol content. This fraction is recognized as the soluble polyphenols (SPP). However, the residue generated may still contain a significant amount of bioactive compounds. Insoluble-bound polyphenols (IBPP) are bound to the cell walls of the plant material. The analysis of the contribution of IBPPs to the total phenolic content of selected fruits and vegetables resulted in a mean of 57%, demonstrating its importance and high variability among vegetable sources [6]. The contribution of insoluble-bound phenolics depends on several aspects such as the nature of tested material (e.g., fruits, vegetables, cereals, legumes, and processing by-products) as well as the portion being analyzed (e.g., flesh, skin, leaf, stem, seeds). IBPP made a minor contribution to the total phenolic and total flavonoid contents of all six cranberry genotypes evaluated by Abeywickrama et al. [7]. IBPP from potato peel rendered as many total phenolics as the SPP fraction (free plus esterified phenolics). In contrast, IBPP from potato flesh did not contribute significantly to the total phenolic content of it [8]. Similarly, the content of IBPP in date seeds and leaves were negligible [9]. Wheat, rice, and some other cereals are good sources of IBPP while SPP was the most prominent fraction in millets [10,11,12,13]. The presence of IBPP was reported for peanuts, beans, lentils, and soybeans, among other legumes [14,15,16,17]. Likewise, IBPP were investigated in various plant food by-products [18].
Although a higher total phenolic content may suggest a higher potential inhibition against alpha-glucosidase, increasing evidence indicates that structural features of specific molecules involved may more appropriately explain the inhibition as discussed in detail elsewhere [19]. In short, it might be concluded that phenolic acids show lower inhibitory activity compared to flavonoids and that these are also influenced by the number of hydroxyl groups present in the molecules. In the case of proanthocyanidins (condensed tannins), polymeric structures show higher inhibitory activity compared to their monomeric counterparts (e.g., catechin and epicatechin). Due to their presence in the bound form in nature, the potential health effects of IBPPs are mainly related to gut health, with modulation of gut bacteria, protection of the colon mucosa, which may lead to systemic effects [20,21,22].
Another important strategy for harnessing the potential of the insoluble-bound polyphenols is increasing their bioavailability through auxiliary methods such as enzyme-assisted extraction, fermentation, and germination [23], which increases the ratio of the soluble to insoluble-bound phenolic compounds in a given sample. Other methods to improve the release of IBPP from the cell wall of the plant material include high-pressure- and ultrasound-assisted extraction [24,25]. The use of these methods has a positive impact on their potential health effects and opens new avenues in the development of functional foods and dietary supplements [26,27].
The Brazilian Food Supplement Law recently recognized that guarana contains bioactive substances, hence supporting its role as a functional food ingredient [28]. Both animal and human studies have found that the consumption of guarana powder was safe and caused no toxicity in small doses (30 mg/kg for animals and 200 mg/day for humans) [29,30]. While the composition of the soluble polyphenols from guarana is well established and reported [5,31,32,33], there is a clear gap in the available literature regarding the insoluble-bound fraction as a source of bioactive compounds. Considering that the guarana powder is traditionally consumed as a whole, as opposed to a water-based extract, the IBPPs are also ingested and may contribute to the overall health effects of guarana consumption. Moreover, as in other feedstocks [34], the residue generated from the production of guarana syrup might be explored for its insoluble-bound bioactive compounds.
The World Health Organization estimates that 422 million adults have diabetes worldwide, with an ascendant tendency brought by the increased incidence of type 2 diabetes [35]. Problems associated with diabetes include skin complications related to bacterial and fungal infections, ocular complications that may lead to blindness, and nerve damage, also known as diabetic neuropathy [16]. Furthermore, systemic inflammation and oxidative stress may also be involved [36,37]. The increasing intake of sweetened food and beverages elevates the risk of insulin resistance, which consequently decreases hepatic insulin sensitivity and triggers the onset of type 2 diabetes [38,39].
One of the strategies employed in the management of this metabolic disorder is the inhibition of carbohydrate-hydrolyzing enzymes, such as alpha-amylase and alpha-glucosidase, in order to control post-prandial glucose levels. In some countries such as Brazil and Argentina, among others, anti-hyperglycemics are provided by the government to the population free of charge in order to relieve the affected population from associated economic burden [40]. The side effects of acarbose, the most studied inhibitor of alpha-glucosidase, include abdominal distention, flatulence, meteorism, and, possibly, diarrhea [41]. In this way, bioactive compounds that might have an effect on the activity of these enzymes are of interest for human health promotion [42], with new techniques being developed for the discovery and screening of enzyme inhibitors found in herbs and foods [43].
Alpha-glucosidase is located in the brush border of the small intestine. It is well known that insoluble-bound phenolics have a negligible reactivity in this location, being more active after colonic fermentation. However, before investing time and financial resources in different methods (e.g., enzyme treatment and/or fermentation) to increase the concentration of soluble phenolics [26,27], which could provide a higher concentration of phenolic bioactives in the small intestine, one needs to make sure that the phenolics released from the cell wall of the plant material do actually bind to alpha-glucosidase. Accordingly, the present study focused on the presence of insoluble-bound polyphenols in guarana powder and evaluated its inhibition of the carbohydrate-hydrolyzing enzymes. The identification of the phenolic compounds was carried out by MALDi-TOF-MS. In short, our contribution may have an impact on the procurement of nutraceuticals and functional ingredients for the management and/or prevention of type 2 diabetes. The fraction containing soluble phenolics was also evaluated for comparative purposes.

2. Results and Discussion

2.1. Screening

In general, screening methods have low specificity, which may lead to over- or underestimation of the real values, but they have the advantage of being well-established and allow for the comparison of different samples. The total phenolic content (TPC) method is based on a redox reaction, and as such, it is dependent on the redox potential of the sample components. For polyphenols, their oxidation susceptibility is influenced by the degree of hydroxylation of the B-ring, the catechol group attached to the C2 position of the chromane ring and mainly associated with the antioxidant and metal chelating properties of polyphenols -, along with the presence of other reducing agents [44]. Certain sugars, amino acids, vitamin C, and other organic acids may influence the TPC values [45]. Due to the hydrolysis method, the IBPP fraction was further purified with solid-phase extraction (SPE) for the removal of interfering substances.
The TPC of the SPP and the IBPP fractions were 65.16 ± 0.19 mg and 3.97 ± 0.02 mg GAE/g of guarana powder (dw), respectively. The TPC values reported in the literature for the extractable polyphenols of guarana powder vary considerably and range from 8.4 to 151.8 mg GAE/g of the sample [5,46]. Different methods of extraction, as well as different origins of the guarana powder, explain the large variability of the results. In this way, the SPP fraction value is within the range expected for the sample. In contrast, there are no previous reports in the literature regarding the insoluble-bound polyphenol content of guarana powder, but similar investigations of green tea and dried persimmon resulted in the IBPPs contributing to 19 and 4% to the TPC, respectively [47,48], while the IBPP fraction of the guarana powder sample contributed 6% to the total value, although the hydrolyzation may impact the screening results. Different extraction methods, such as enzyme-assisted or fermentation, may be used in the future in order to release a higher proportion of the insoluble-bound polyphenols from the matrix [49].

2.2. Alpha-Glucosidase Inhibition Assay

The SPP and IBPP fractions inhibited the alpha-glucosidase activity in a dose-dependent manner. Their half-maximal inhibitory dose (IC50) was 9.50 and 1.624 µg GAE/mL, respectively (Figure 1). The efficacy of the IBPP fraction is also supported by its lower IC50 value compared to that of acarbose, which ranged from 36.0 to 107.3 µg/mL [50,51]. Green tea, oolong tea, and black tea had IC50 values of 10.02, 1.38, and 2.25 µg/mL, respectively [52,53]. Therefore, the values obtained for guarana powder are comparable to other well-established sources of polyphenols and even lower than that of acarbose, which is the most studied inhibitor of alpha-glucosidase.
The IC50 of SPP was approximately 6 times higher in comparison with the IBPP result. In a study with the soluble and insoluble-bound polyphenols of green tea, the inhibitory activity of the IBPP was 2.5 times higher than the SPP [48]. The difference in trend might stem from a distinction in the composition of the samples, which has a direct impact on the interactions with the enzyme.

2.3. Mode of Inhibition

Enzyme inhibitors can be classified into two main classes: reversible and irreversible inhibitors. Irreversible inhibitors bind permanently to the enzyme and display steady-state velocities that approach zero, which can visually be assessed with a reaction progress curve. The progress curves for the alpha-glucosidase in the presence of SPP and IBPP are linear, indicating that they can be classified as reversible inhibitors (Figure 2) [54].
Reversible inhibitors can be competitive, non-competitive, or mixed inhibitors based on how they interact with the enzyme, and these interactions have a direct impact on the values of the Michaelis constant (Km) and the maximum rate (Vmax). Competitive inhibitors compete directly with the substrate to bind in the enzyme’s active site, while non-competitive inhibitors bind to the enzyme-substrate complex outside of the active site. Lastly, mixed inhibitors bind to both the enzyme and the complex enzyme-substrate, outside of the active site of the enzyme. Consequently, in the presence of a mixed inhibitor, the values of Km and Vmax are altered in relation to the equilibrium constants, KI and K’I. The Lineweaver–Burk plot offers a useful visual aid to identify the mode of inhibition for both the SPP and IBPP, the data lines had a different slope and a different intercept in comparison to the control plot, and the lines intersected in the second quadrant of the graph (Figure 3). In this way, SPP and IBPP can be classified as mixed reversible inhibitors for the alpha-glucosidase, and the Lineweaver–Burk linear equation can be written as follows [55]:
1 V 0 = 1 + I K I × K m V m a x × 1 S + 1 + I K I × 1 V m a x
where [I] is the inhibitor concentration.
The inhibition kinetic parameters for alpha-glucosidase in the presence of SPP and IBPP were calculated based on Equation (1) and the appropriate mathematical relations. The equilibrium constants are expressed in Equation (2):
K I = E I E I         K I = E S I E S I
where [E] is the concentration of the enzyme, [I] is the concentration of the inhibitor, [EI] is the concentration of the complex enzyme-inhibitor, [ES] is the concentration of the complex enzyme-substrate, and [ESI] is the concentration of the complex enzyme-substrate-inhibitor. The inhibition kinetic parameters are presented in Table 1:
Equilibrium constants higher than 1 suggest that there are fewer inhibitors bound to the enzyme than in its free form, while constants lower than 1 suggest the opposite. In both cases, the KI values were smaller than the KI’ values, indicating that SPP and IBPP bind more effectively to the free enzyme than to the enzyme-substrate complex. This difference is more pronounced in the SPP fraction, for which its KI’ value > 1 suggests that it binds poorly to the ES complex.
As evidenced by the enzymatic assay, the polyphenols of the guarana powder that are bound to the cell wall matrix have potential biological activities that remain unexplored. The interaction between phenolic compounds and proteins, which includes their capacity to inhibit enzymes, is related to their structure, size, number and position of substituents, and polyphenol complexity [56]. To the best of our knowledge, there are no published studies addressing the phenolic composition of the insoluble-bound polyphenols of guarana.

2.4. Insoluble-Bound Phenolic Profile

The soluble phenolic profile of guarana powder is well known and reported in the literature [5,31,32,33]. The main components are catechin and its isomer, epicatechin, and proanthocyanidin dimers.
Interactions between phenolic compounds and polysaccharides result in a major component in the occurrence of insoluble-bound polyphenols. When the cell wall is ruptured, as occurring during the grinding of the guarana seed to produce the guarana powder, polysaccharides and polyphenols interact rapidly non-covalently via a combination of hydrogen bonds and hydrophobic interactions between the phenolic compounds and the pectic fraction of the cell wall. The guarana powder pectin fraction is formed mostly of a homogalacturonan chain, similar to the composition found in apple pomace, which is another product recognized for its high proportion of insoluble polyphenols [57,58].
The MALDI spectra of the insoluble-bound polyphenol fraction of guarana powder have the periodic clusters that are consistent with the analysis of polymeric/oligomeric structures, namely proanthocyanidins. The ion clusters are large, which indicates a mixture of types of oligomers (Figure 4). This complexity may be attributed in part to the alkaline hydrolysis, as it has been demonstrated that alkaline conditions are capable of cleaving the interflavan bond, and the presence of oxygen can cause further degradation. Additionally, the carbocation produced in the depolymerization process can react with other polyphenols in the solution, which may lead to the formation of hetero-oligomers and a higher proportion of dimers [59,60].
Plant-derived proanthocyanidin structures vary depending on the monomeric units, interflavan linkage type, hydroxylation pattern of the rings, and stereochemistry of the non-aromatic ring, complicating its characterization. The possible identities were calculated using the most common monomeric units of proanthocyanidins: (epi)afzelechin (MM: 274.084), (epi)catechin (MM: 290.079) and (epi)gallocatechin (MM: 306.074) (Figure 5). The insoluble-bound proanthocyanidins of guarana powder were detected as oligomers of low molecular weight (DP ≤ 5). However, larger oligomers may have their detection impaired by the saturation of the detector by the smaller compounds [61]. Therefore, their presence cannot be discarded.
There are two distinct sets of compounds identifiable in the MALDI spectra. The first set corresponds to the proanthocyanidins composed of the most common monomers. Propelargonidins and procyanidins were detected, but no prodelphinidins were noticed. The peaks sets are comprised of series with varying degrees of hydroxylation, as evidenced by the 16 Da increments (Figure 6). These increments indicate the existence of hetero-oligomers, i.e., oligomers composed of a mixture of monomeric units. As expected due to the soluble polyphenol composition, galloylated compounds were not detected. Additionally, the majority of the interflavan linkage identified was of type-A [62,63,64]. The IBPP fraction composition is summarized in Table 2:
The second set has a periodicity of 280 Da, which does not correspond to a known flavan-3-ol compound. The periodic clusters indicate that this set is comprised of oligomeric structures, and the 16 Da increments are also evidence of different hydroxylation patterns within the set. Although the identities of the compounds cannot be elucidated, they may be modified flavan-3-ol structures caused by depolymerization processes and/or the laser treatment [65,66].
In the latest years, several studies reported the presence of proanthocyanidins in the insoluble-bound fraction released from the cell wall [67,68,69]. In this way, the phenolic profile indicating the presence of dimeric and oligomeric proanthocyanidins linked to the cell wall of the plant material is consistent with the literature. The interaction between proteins and polyphenols are facilitated with the presence of polyphenols of higher molecular weight [70], which may help understand why the insoluble-bound fraction was seemingly more effective in the inhibition of the alpha-glucosidase. The IBPP fraction of the guarana powder has several oligomers bearing varying degrees of hydroxylation, thus providing different bond and interaction sites for the formation of the polyphenol-enzyme complex. Additionally, although afzelechin has never been identified in the SPP fraction of guarana powder, it was found to be present in the IBPP fraction and a recent study has shown a positive relationship between the proportion of dimers as well as the proportion of afzelechin extension units in proanthocyanidin fractions and their alpha-glucosidase inhibition capacity [71]. This difference between the SPP and IBPP composition may be an important factor for their effectiveness as alpha-glucosidase inhibitors. Likewise, according to the literature, the main soluble phenolic compounds present in guarana powder are monomers and dimers: catechin, epicatechin, procyanidin B1 and procyanidin B2. The presence of oligomers (trimers and tetramers) in the most active fraction (IBPP) lends support to a previous report [19] in which the authors suggested that, considering condensed tannins, oligomeric structures (<10 monomeric units) exhibit higher inhibitory activity compared to monomeric flavonoids.
The revised Brazilian normative on food supplements has been recently discussed by de Camargo and Silva [72]. Proanthocyanidins were mentioned among a few other phenolic compounds. However, only cranberry powder was mentioned as a source of proanthocyanidins. Guarana powder is listed as a well-known source of caffeine. However, the present study lends support to the suggestion made by these authors that guarana must be included as a Brazilian source of proanthocyanidins.

3. Materials and Methods

3.1. Materials

Guarana powder was purchased from a local market (São Paulo, Brazil). All solvents and reagents were of analytical grade or higher. Catechin, epicatechin, alpha-glucosidase (from Saccharomyces cerevisiae), and 4-nitrophenyl-α-d-glucopyranoside (pNPG) were purchased from Sigma-Aldrich (St. Louis, MO, USA).

3.2. Soluble Polyphenol (SPP) Fraction Obtention

Homogenized guarana powder samples (0.8 g) were suspended in 20 mL of distilled water, methanol, and acetone (20:56:24, v/v/v), followed by homogenization with Ultra-Turrax (IKA T18 Basic, Taquara, Rio de Janeiro, Brazil) at 14,000 rpm for 3 min and centrifugation at 18,000× g for 15 min (Centrifuge 3–18 K, Sigma Laborzentrifugen, Osterode, Germany) [73]. Four extraction cycles were completed successively, and the supernatants were pooled together after filtration to remove solid impurities. The final volume (100 mL) was adjusted with distilled water, and the extract was stored in an amber flask at 4 °C.

3.3. Insoluble-Bound Polyphenol (IBPP) Fraction Obtention

The solid residue from the hydro-organic extraction was lyophilized and homogenized prior to its utilization. Residue samples (50 mg) were combined with 2 mL of 2 M NaOH, and the mixture was flushed with N2. The ultrasound-assisted (37 kHz and 100 W) reaction was carried out at 60 °C for 15 min. The solution pH was neutralized with 4 M HCl and, subsequently 2 mL of acetone-distilled water-acetic acid (70:29.5:0.5, v/v/v) was added to the solution, followed by homogenization with Ultra-Turrax at 14,000 rpm for 1 min and centrifugation at 10,000× g for 10 min [60]. Three extraction cycles were completed successively, and the supernatants were pooled together after filtration to remove solid impurities. The final volume (10 mL) was adjusted with distilled water, and the extract was stored in an amber flask at 4 °C.
The extract was further purified with solid-phase extraction (SPE) for the removal of salts, sugars, and other possible interferents. Briefly, the sample was diluted in a 0.1% acetic acid solution (1:1, v/v), and then loaded into a previously activated and equilibrated OASIS SEP-PAK cartridge (3 cc, 500 mg). The cartridge was flushed with 0.1% acetic acid solution, and the sample was eluted with acidified methanol (0.1% acetic acid) at a rate of 1 mL/min [74]. The eluted sample was stored in an amber flask at −20 °C.

3.4. Total Phenolic Content (TPC)

The appropriately diluted SPP and IBPP fractions (120 µL) were added to a transparent polystyrene microplate, followed by 50 µL of a 20% Folin-Ciocalteu reagent solution. The mixture was briefly homogenized and incubated at room temperature for 3 min. After this period, 30 µL of sodium carbonate (200 g/L) was added to the solution, and the mixture was homogenized and incubated at 37 °C for 1 h [75]. The sample absorbance was measured at 765 nm with a Molecular devices spectrophotometer (SPECTRAmax, Sunnyvale, CA, USA). Gallic acid was the standard for the calibration curve. The results were expressed as milligram of gallic acid equivalents per gram of dry weight of guarana powder or residue (mg GAE/g dw).

3.5. Enzymatic Assays

The SPP and IBPP samples had their organic solvents eliminated in a centrifugal vacuum concentrator (CentriVap) and were re-dissolved in water prior to the enzymatic analysis. Phosphate buffer (0.1 M, pH 6.8) was used in the assay.
For alpha-glucosidase inhibition assay, 80 µL of the samples in different concentrations were added to a transparent polystyrene microplate, followed by 20 µL of 0.2 U/mL of alpha-glucosidase. The mixture was briefly homogenized and incubated at 37 °C for 5 min. After this period, 100 µL of 4 mM pNPG was added to the solution, and the mixture was homogenized and incubated at 37 °C for 30 min. The reaction was stopped by adding 100 µL of 4 mM sodium carbonate, and the formation of p-nitrophenol was measured at 405 nm with a Molecular Devices spectrophotometer (SPECTRAmax, Sunnyvale, CA, USA). The inhibition percentage was determined according to Equation (3). The half-maximal inhibitory concentration (IC50) was calculated with the construction of a dose-response curve and non-linear regression.
I n h i b i t i o n   % = 1 A s a m p l e A b l a n k A t e s t A c o n t r o l × 100
where Asample is the absorbance of the reactive medium, Ablank is the absorbance of the reactive medium excluding the enzyme, Atest is the absorbance of the reactive medium excluding the sample, and Acontrol is the absorbance of the reactive medium excluding the sample and the enzyme.
The inhibition mode was investigated similar to the previous assay, but using a wide range of pNPG concentration to reach enzyme saturation and keeping the concentration of the enzyme and the inhibitor (SPP and IBPP) constants. The 30-min reaction was monitored at 405 nm with a Molecular Devices spectrophotometer (SPECTRAmax) in the kinetic mode. The kinetic parameters were calculated with the construction of a curve representing the relation between initial velocity (V0) and substrate concentration ([S]), the linearization of Lineweaver–Burk (Equation (4)), and the appropriate mathematical relations [48,54,55].
1 V 0 = K m V m a x × 1 S + 1 V m a x
where Km is the Michaelis constant, and Vmax is the maximum velocity.

3.6. Mass Spectroscopy Analysis of the IBPP Fraction

The phenolic profile of the IBPP fraction was analyzed by matrix-assisted laser desorption/ionization (MALDI-TOF-MS, MALDI UltrafleXtreme Bruker Daltonics, Billerica, MA, USA). The ionization source was an attenuated N2 laser beam, with a repetition rate of 1000 Hz and 1500 shots. 2,5-dihydroxybenzoic acid (DHB) was initially tested as a matrix, but the best quality spectra were obtained without the use of a matrix. The sample was diluted in methanol, deposited onto the target, and left to dry out at room temperature. The data was acquired in the positive reflector mode. To determine the possible identities of the peaks by comparison, the ion mass was calculated according to Equation (5):
M + H + = M m + 152.011 × G D P 1 × L × 1.008
where Mm is the molecular mass of monomers, G is the number of esterified galloyl substituents, DP is the degree of polymerization, and L is the type of interflavan bond (type-A, L = 4; type-B, L = 2) [61].

3.7. Data Analysis

The results were expressed as mean ± standard deviation (n = 3). All the data analysis and calculations were performed using the software OriginPro (OriginLab, version 2016, Northampton, MA, USA) and Microsoft Excel. The statistical analysis (Tukey’s test, p < 0.05) was performed using the software Statistical Package for the Social Sciences (SPSS version 24.0, SPSS Inc., Armonk, NY, USA).

4. Conclusions

Guarana powder, which has been recently mentioned amongst the trends in food bioactives [76], includes a range of polyphenols that remain in the residue after the conventional extraction of soluble phenolics. Insoluble-bound polyphenols showed a higher efficacy (lower IC50) in inhibiting alpha-glucosidase compared to that of soluble phenolics. Fourteen proanthocyanidins (dimers to tetramers) were possibly identified in the fraction containing insoluble-bound phenolics by MALDI-TOF-MS, suggesting their role as alpha-glucosidase inhibitors. This was the first step in prospecting the potential bioactivity of the phenolics present in the insoluble-bound form in terms of alpha-glucosidase inhibition. However, to release a higher proportion of them from the cell wall matrix, possibly increasing the concentration of soluble phenolics in the small intestine, other processes (e.g., enzyme-assisted extraction and/or fermentation) should be employed. The results presented here may have an impact on the procurement of nutraceuticals and functional ingredients related to the prevention and/or management of type 2 diabetes.

Author Contributions

Conceptualization, A.C.d.C.P., E.A.F.S.T., and G.R.S.; methodology, A.C.d.C.P. and G.R.S.; validation, A.C.d.C.P. and G.R.S.; formal analysis, A.C.d.C.P., and M.J.S.; investigation, A.C.d.C.P.; resources, E.A.F.S.T., and G.R.S.; data curation, A.C.d.C.P.; writing—original draft preparation, A.C.d.C.P.; writing—review and editing, A.C.d.C., E.A.F.S.T, and F.S.; supervision, E.A.F.S.T.; project administration, A.C.d.C.P., E.A.F.S.T., and G.R.S.; funding acquisition, E.A.F.S.T. All authors have read and agreed to the published version of the manuscript.

Funding

A.C.d.C.P. (MSc fellowship) and M.J.S (MSc fellowship) acknowledge CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil, Finance Code 001). A.C.d.C. acknowledges Fondo Nacional de Desarrollo Científico y Tecnológico-FONDECYT postdoctorado (project 3180432). F.S. thanks the Natural Science and Engineering Research Council (NSERC) of Canada for partial financial support. E.A.F.S.T., P.L. (process 2017/20039-0) acknowledges FAPESP (São Paulo Research Foundation).

Acknowledgments

The National Council of Scientific and Technologic Development (CNPq, Brazil) conferred a grant to E.A.F.S.T.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

SPPSoluble polyphenol
IBPPInsoluble-bound polyphenol
MALDIMatrix-assisted Laser Desorpsion/Ionization
TPCTotal Phenolic Content

References

  1. Smith, N.; Atroch, A.L. Guarana’s Journey from regional tonic to aphrodisiac and global energy drink. Evidence-Based Complement. Altern. Med. 2010, 7, 279–282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Haskell, C.F.; Kennedy, D.O.; Wesnes, K.A.; Milne, A.L.; Scholey, A.B. A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guarana in humans. J. Psychopharmacol. 2007, 21, 65–70. [Google Scholar] [CrossRef] [PubMed]
  3. Krewer, C.D.; Ribeiro, E.E.; Ribeiro, E.A.M.; Moresco, R.N.; da Rocha, M.; Montagner, G.; Machado, M.M.; Viegas, K.; Brito, E.; da Cruz, I.B.M. Habitual intake of guarana and metabolic morbidities: An epidemiological study of an elderly Amazonian population. Phyther. Res. 2011, 25, 1367–1374. [Google Scholar]
  4. Lima, N.D.; Teixeira, L.; Gambero, A.; Ribeiro, M.L. Guarana (Paullinia cupana) stimulates mitochondrial biogenesis in mice fed high-fat diet. Nutrients 2018, 10, 12. [Google Scholar]
  5. Yonekura, L.; Martins, C.A.; Sampaio, G.R.; Monteiro, M.P.; Cesar, L.A.M.; Mioto, B.M.; Mori, C.S.; Mendes, T.M.N.; Ribeiro, M.L.; Arcari, D.P.; et al. Bioavailability of catechins from guarana (Paullinia cupana) and its effect on antioxidant enzymes and other oxidative stress markers in healthy human subjects. Food Funct. 2016, 7, 2970–2978. [Google Scholar] [CrossRef] [PubMed]
  6. Perez-Jimenez, J.; Diaz-Rubio, M.E.; Saura-Calixto, F. Contribution of macromolecular antioxidants to dietary antioxidant capacity: A study in the Spanish mediterranean diet. Plant Foods Hum. Nutr. 2015, 70, 365–370. [Google Scholar] [CrossRef]
  7. Abeywickrama, G.; Debnath, S.C.; Ambigaipalan, P.; Shahidi, F. Phenolics of selected cranberry cenotypes (Vaccinium macrocarpon Ait.) and their antioxidant efficacy. J. Agric. Food Chem. 2016, 64, 9342–9351. [Google Scholar] [CrossRef]
  8. Albishi, T.; John, J.A.; Al-Khalifa, A.S.; Shahidi, F. Phenolic content and antioxidant activities of selected potato varieties and their processing by-products. J. Funct. Foods 2013, 5, 590–600. [Google Scholar] [CrossRef]
  9. John, J.A.; Shahidi, F. Phenolic content, antioxidant and anti-inflammatory activities of seeds and leaves of date palm (Phoenix dactylifera L.). J. Food Bioact. 2019, 5, 120–130. [Google Scholar] [CrossRef] [Green Version]
  10. Liyana-Pathirana, C.M.; Shahidi, F. Importance of insoluble-bound phenolics to antioxidant properties of wheat. J. Agric. Food Chem. 2006, 54, 1256–1264. [Google Scholar] [CrossRef]
  11. Kim, K.-H.; Tsao, R.; Yang, R.; Cui, S.W. Phenolic acid profiles and antioxidant activities of wheat bran extracts and the effect of hydrolysis conditions. Food Chem. 2006, 95, 466–473. [Google Scholar] [CrossRef]
  12. Pang, Y.; Ahmed, S.; Xu, Y.; Beta, T.; Zhu, Z.; Shao, Y.; Bao, J. Bound phenolic compounds and antioxidant properties of whole grain and bran of white, red and black rice. Food Chem. 2018, 240, 212–221. [Google Scholar] [CrossRef] [PubMed]
  13. Kumari, D.; Chandrasekara, A.; Shahidi, F. Bioaccessibility and antioxidant activities of finger millet food phenolics. J. Food Bioact. 2019, 6, 100–109. [Google Scholar] [CrossRef]
  14. Wang, Y.-K.; Zhang, X.; Chen, G.-L.; Yu, J.; Yang, L.-Q.; Gao, Y.-Q. Antioxidant property and their free, soluble conjugate and insoluble-bound phenolic contents in selected beans. J. Funct. Foods 2016, 24, 359–372. [Google Scholar] [CrossRef]
  15. Alshikh, N.; de Camargo, A.C. Phenolics of selected lentil cultivars: Antioxidant activities and inhibition of low-density lipoprotein and DNA damage. J. Funct. Foods 2015, 18, 1022–1038. [Google Scholar] [CrossRef]
  16. de Camargo, A.C.; Regitano-d’Arce, M.A.B.; Shahidi, F. Phenolic profile of peanut by-products: Antioxidant potential and inhibition of alpha-glucosidase and lipase activities. J. Am. Oil Chem. Soc. 2017, 94, 959–971. [Google Scholar] [CrossRef]
  17. Gao, Y.; Ma, S.; Wang, M.; Feng, X.-Y. Characterization of free, conjugated, and bound phenolic acids in seven commonly consumed vegetables. Molecules 2017, 22, 1878. [Google Scholar] [CrossRef] [Green Version]
  18. de Camargo, A.C.; Schwember, A.R.; Parada, R.; Garcia, S.; Maróstica, M.R.; Franchin, M.; Regitano-d’Arce, M.A.B.; Shahidi, F. Opinion on the hurdles and potential health benefits in value-added use of plant food processing by-products as sources of phenolic compounds. Int. J. Mol. Sci. 2018, 19, 3498. [Google Scholar] [CrossRef] [Green Version]
  19. de Camargo, A.C.; Favero, B.T.; Morzelle, M.C.; Franchin, M.; Alvarez-Parrilla, E.; de la Rosa, L.A.; Geraldi, M.V.; Maróstica Júnior, M.R.; Shahidi, F.; Schwember, A.R. Is chickpea a potential substitute for Soybean? Phenolic bioactives and potential health benefits. Int. J. Mol. Sci. 2019, 20, 2644. [Google Scholar] [CrossRef] [Green Version]
  20. Cires, M.J.; Wong, X.; Carrasco-Pozo, C.; Gotteland, M. The gastrointestinal tract as a key target organ for the health-promoting effects of dietary proanthocyanidins. Front Nutr. 2016, 3, 57. [Google Scholar] [CrossRef] [Green Version]
  21. Wong, X.; Carrasco-Pozo, C.; Escobar, E.; Navarrete, P.; Blachier, F.; Andriamihaja, M.; Lan, A.; Tomé, D.; Cires, M.J.; Pastene, E.; et al. Deleterious fffect of p-cresol on human colonic epithelial cells prevented by proanthocyanidin-containing polyphenol extracts from fruits and proanthocyanidin bacterial metabolites. J. Agric. Food Chem. 2016, 64, 3574–3583. [Google Scholar] [CrossRef] [PubMed]
  22. Casanova-Marti, A.; Serrano, J.; Portune, K.J.; Sanz, Y.; Blay, M.T.; Terra, X.; Ardevol, A.; Pinent, M. Grape seed proanthocyanidins influence gut microbiota and enteroendocrine secretions in female rats. Food Funct. 2018, 9, 1672–1682. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Yeo, J.; Shahidi, F. Critical evaluation of changes in the tatio of insoluble bound to soluble phenolics on antioxidant activity of lentils during germination. J. Agric. Food Chem. 2015, 63, 379–381. [Google Scholar] [CrossRef] [PubMed]
  24. Garcia-Mora, P.; Peñas, E.; Frias, J.; Zieliński, H.; Wiczkowski, W.; Zielińska, D.; Martínez-Villaluenga, C. High-pressure-assisted enzymatic release of peptides and phenolics increases angiotensin converting enzyme I inhibitory and antioxidant activities of pinto bean hydrolysates. J. Agric. Food Chem. 2016, 64, 1730–1740. [Google Scholar] [CrossRef] [Green Version]
  25. Silva, M.B.R.; Falcão, H.G.; Kurozawa, L.E.; Prudencio, S.H.; Camargo, A.C.; de Shahidi, F.; Ida, E.I. Ultrasound- and hemicellulase-assisted extraction increase β-glucosidase activity, the content of isoflavone aglycones and antioxidant potential of soymilk. J. Food Bioact. 2019, 6. [Google Scholar] [CrossRef] [Green Version]
  26. De Camargo, A.C.; Regitano-D’Arce, M.A.B.; Biasoto, A.C.T.; Shahidi, F. Enzyme-assisted extraction of phenolics from winemaking by-products: Antioxidant potential and inhibition of alpha-glucosidase and lipase activities. Food Chem. 2016, 212, 395–402. [Google Scholar] [CrossRef] [Green Version]
  27. Bautista-Expósito, S.; Martínez-Villaluenga, C.; Dueñas, M.; Silván, J.M.; Frias, J.; Peñas, E. Combination of pH-controlled fermentation in mild acidic conditions and enzymatic hydrolysis by Savinase to improve metabolic health-promoting properties of lentil. J. Funct. Foods 2018, 48, 9–18. [Google Scholar] [CrossRef] [Green Version]
  28. Silva, C.P.; Soares-Freitas, R.A.M.; Sampaio, G.R.; de Camargo, A.C.; Torres, E.A.F.S. Guarana as a source of bioactive compounds. J. Food Bioact. 2019, 6, 1–5. [Google Scholar] [CrossRef]
  29. Antonelli-Ushirobira, T.M.; Kaneshima, E.N.; Gabriel, M.; Audi, E.A.; Marques, L.C.; Mello, J.C.P. Acute and subchronic toxicological evaluation of the semipurified extract of seeds of guarand (Paullinia cupana) in rodents. Food Chem. Toxicol. 2010, 48, 1817–1820. [Google Scholar] [CrossRef]
  30. Dorneles, I.M.P.; Fucks, M.B.; Fontela, P.C.; Frizzo, M.N.; Winkelmann, E.R. Guarana (Paullinia cupana) presents a safe and effective anti-fatigue profile in patients with chronic kidney disease: A randomized, double-blind, three-arm, controlled clinical trial. J. Funct. Foods 2018, 51, 1–7. [Google Scholar] [CrossRef]
  31. da Silva, G.S.; Canuto, K.M.; Ribeiro, P.R.V.; de Brito, E.S.; Nascimento, M.M.; Zocolo, G.J.; Coutinho, J.P.; de Jesus, R.M. Chemical profiling of guarana seeds (Paullinia cupana) from different geographical origins using UPLC-QTOF-MS combined with chemometrics. Food Res. Int. 2017, 102, 700–709. [Google Scholar] [CrossRef] [PubMed]
  32. Dias, T.; Silva, M.R.; Damiani, C.; da Silva, F.A. Quantification of catechin and epicatechin in foods by enzymatic-spectrophotometric method with tyrosinase. Food Anal. Methods 2017, 10, 3914–3923. [Google Scholar] [CrossRef]
  33. Machado, K.N.; de Freitas, A.A.; Cunha, L.H.; Faraco, A.A.G.; de Padua, R.M.; Braga, F.C.; Vianna-Soares, C.D.; Castilho, R.O. A rapid simultaneous determination of methylxanthines and proanthocyanidins in Brazilian guarana (Paullinia cupana Kunth.). Food Chem. 2018, 239, 180–188. [Google Scholar] [CrossRef] [PubMed]
  34. Shahidi, F.; Varatharajan, V.; Oh, W.Y.; Peng, H. Phenolic compounds in agri-food by-products, their bioavailability and health effects. J. Food Bioact. 2019, 5, 57–119. [Google Scholar] [CrossRef] [Green Version]
  35. World Health Organization: Diabetes. Available online: https://www.webcitation.org/70RGtswSF (accessed on 25 June 2018).
  36. Zhang, H.; Tsao, R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr. Opin. Food Sci. 2016, 8, 33–42. [Google Scholar] [CrossRef]
  37. de Camargo, A.C.; Biasoto, A.C.T.; Schwember, A.R.; Granato, D.; Rasera, G.B.; Franchin, M.; Rosalen, P.L.; Alencar, S.M.; Shahidi, F. Should we ban total phenolics and antioxidant screening methods? The link between antioxidant potential and activation of NF-κB using phenolic compounds from grape by-products. Food Chem. 2019, 290, 229–238. [Google Scholar] [CrossRef]
  38. Jiao, Y.; Wang, Y. The effects of sweeteners and sweetness enhancers on obesity and diabetes: A review. J. Food Bioact. 2018, 4, 107–116. [Google Scholar] [CrossRef] [Green Version]
  39. Lange, K.W.; Hauser, J.; Kaunzinger, I.; Nakamura, Y.; Reissmann, A.; Stollberg, E.; Guo, J.; Li, S. Chronic increase in sugar consumption and visual attention in Wistar rats. J. Food Bioact. 2018, 3, 161–167. [Google Scholar] [CrossRef] [Green Version]
  40. Shahidi, F.; de Camargo, A.C. Tocopherols and tocotrienols in common and emerging dietary sources: Occurrence, applications, and health benefits. Int. J. Mol. Sci. 2016, 17, 1745. [Google Scholar] [CrossRef]
  41. Chiasson, J.L.; Josse, R.G.; Gomis, R.; Hanefeld, M.; Karasik, A.; Laakso, M. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet 2002, 359, 2072–2077. [Google Scholar] [CrossRef]
  42. Williamson, G. Possible effects of dietary polyphenols on sugar absorption and digestion. Mol. Nutr. Food Res. 2013, 57, 48–57. [Google Scholar] [CrossRef] [PubMed]
  43. Li, L.; Tsao, R. UF-LC-DAD-MSn for discovering enzyme inhibitors for nutraceuticals and functional foods. J. Food Bioact. 2019, 7, 27–35. [Google Scholar] [CrossRef] [Green Version]
  44. Rohr, G.E.; Meier, B.; Sticher, O. Analysis of procyanidins. Stud. Nat. Prod. Chem. 2000, 21, 497–570. [Google Scholar]
  45. Ambigaipalan, P.; de Camargo, A.C.; Shahidi, F. Phenolic compounds of pomegranate byproducts (outer skin, mesocarp, divider membrane) and their antioxidant activities. J. Agric. Food Chem. 2016, 64, 6584–6604. [Google Scholar] [CrossRef]
  46. Basile, A.; Rigano, D.; Contea, B.; Bruno, M.; Rosselli, S.; Sorbo, S. Antibacterial and antifungal activities of acetonic extract from Paullinia cupana Mart. seeds. Nat. Prod. Res. 2013, 27, 2084–2090. [Google Scholar] [CrossRef] [Green Version]
  47. Matsumura, Y.; Ito, T.; Yano, H.; Kita, E.; Mikasa, K.; Okada, M.; Furutani, A.; Murono, Y.; Shibata, M.; Nishii, Y.; et al. Antioxidant potential in non-extractable fractions of dried persimmon (Diospyros kaki Thunb.). Food Chem. 2016, 202, 99–103. [Google Scholar] [CrossRef]
  48. Yan, S.S.; Shao, H.J.; Zhou, Z.H.; Wang, Q.; Zhao, L.H.; Yang, X.B. Non-extractable polyphenols of green tea and their antioxidant, anti-alpha-glucosidase capacity, and release during in vitro digestion. J. Funct. Foods 2018, 42, 129–136. [Google Scholar] [CrossRef]
  49. Domínguez-Rodríguez, G.; Marina, M.L.; Plaza, M. Strategies for the extraction and analysis of non-extractable polyphenols from plants. J. Chromatogr. A 2017, 1514, 1–15. [Google Scholar] [CrossRef]
  50. Kwon, Y.I.; Son, H.J.; Moon, K.S.; Kim, J.K.; Kim, J.G.; Chun, H.S.; Ahn, S.K.; Hong, C.I. Novel alpha-glucosidase inhibitors, CKD-711 and CKD-711a produced by Streptomyces sp. CK-4416. II. Biological properties. J. Antibiot. (Tokyo) 2002, 55, 462–466. [Google Scholar] [CrossRef] [Green Version]
  51. Varghese, G.K.; Bose, L.V.; Habtemariam, S. Antidiabetic components of Cassia alata leaves: Identification through α-glucosidase inhibition studies. Pharm. Biol. 2013, 51, 345–349. [Google Scholar] [CrossRef]
  52. Gao, J.; Xu, P.; Wang, Y.; Wang, Y.; Hochstetter, D. Combined effects of green tea extracts, green tea polyphenols or epigallocatechin gallate with acarbose on inhibition against alpha-amylase and alpha-glucosidase in vitro. Molecules 2013, 18, 11614–11623. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Yang, X.; Kong, F. Evaluation of the in vitro alpha-glucosidase inhibitory activity of green tea polyphenols and different tea types. J. Sci. Food Agric. 2016, 96, 777–782. [Google Scholar] [CrossRef] [PubMed]
  54. Strelow, J.; Dewe, W.; Iversen, P.W.; Brooks, H.B.; Radding, J.A.; Mcgee, J.; Weidner, J. Mechanism of action assays for enzymes. In Assay Guidance Manual; Sittampalan, G., Coussens, N., Brimacombe, K., et al., Eds.; Eli Lilly & Co and the National Center for Advancing Translational Sciences: Bethesda, MD, USA, 2012. [Google Scholar]
  55. Nelson, D.L.; Cox, M.M. Lehninger Principles of Biochemistry, 6th ed.; W. H. Freeman and Company: New York, NY, USA, 2012; ISBN 978-1429234146. [Google Scholar]
  56. Barrett, A.H.; Farhadi, N.F.; Smith, T.J. Slowing starch digestion and inhibiting digestive enzyme activity using plant flavanols/tannins— A review of efficacy and mechanisms. LWT-Food Sci. Technol. 2018, 87, 394–399. [Google Scholar] [CrossRef]
  57. Dalonso, N.; de Oliveira Petkowicz, C.L. Guarana powder polysaccharides: Characterisation and evaluation of the antioxidant activity of a pectic fraction. Food Chem. 2012, 134, 1804–1812. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Renard, C.; Watrelot, A.A.; Le Bourvellec, C. Interactions between polyphenols and polysaccharides: Mechanisms and consequences in food processing and digestion. Trends Food Sci. Technol. 2017, 60, 43–51. [Google Scholar] [CrossRef]
  59. Laks, P.E.; Hemingway, R.W. Condensed tannins: Base-catalysed reactions of polymeric procyanidins with toluene-α-thiol. Lability of the interflavanoid bond and pyran ring. J. Chem. Soc., Perkin Trans. 1 1987, 2, 465–470. [Google Scholar] [CrossRef] [Green Version]
  60. White, B.L.; Howard, L.R.; Prior, R.L. Release of bound procyanidins from cranberry pomace by alkaline hydrolysis. J. Agric. Food Chem. 2010, 58, 7572–7579. [Google Scholar] [CrossRef]
  61. Monagas, M.; Quintanilla-Lopez, J.E.; Gomez-Cordoves, C.; Bartolome, B.; Lebron-Aguilar, R. MALDI-TOF MS analysis of plant proanthocyanidins. J. Pharm. Biomed. Anal. 2010, 51, 358–372. [Google Scholar] [CrossRef]
  62. Wei, S.D.; Zhou, H.C.; Lin, Y.M.; Liao, M.M.; Chai, W.M. MALDI-TOF MS analysis of condensed tannins with potent antioxidant activity from the leaf, stem bark and root bark of Acacia confusa. Molecules 2010, 15, 4369–4381. [Google Scholar] [CrossRef] [Green Version]
  63. Chai, W.M.; Wei, M.K.; Wang, R.; Deng, R.G.; Zou, Z.R.; Peng, Y.Y. Avocado proanthocyanidins as a source of tyrosinase inhibitors: Structure characterization, inhibitory activity, and mechanism. J. Agric. Food Chem. 2015, 63, 7381–7387. [Google Scholar] [CrossRef]
  64. Pérez-Jiménez, J.; Torres, J.L. Analysis of proanthocyanidins in almond blanch water by HPLC-ESI-QqQ-MS/MS and MALDI-TOF/TOF MS. Food Res. Int. 2012, 49, 798–806. [Google Scholar] [CrossRef]
  65. Perez-Ramirez, I.F.; Reynoso-Camacho, R.; Saura-Calixto, F.; Perez-Jimenez, J.; Pérez-Ramírez, I.F.; Reynoso-Camacho, R.; Saura-Calixto, F.; Pérez-Jiménez, J. Comprehensive characterization of extractable and nonextractable phenolic compounds by high-performance liquid chromatography-electrospray ionization-quadrupole time-of-flight of a grape/pomegranate pomace dietary supplement. J. Agric. Food Chem. 2018, 66, 661–673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Ucar, M.B.; Ucar, G.; Pizzi, A.; Gonultas, O. Characterization of Pinus brutia bark tannin by MALDI-TOF MS and 13C NMR. Ind. Crops Prod. 2013, 49, 697–704. [Google Scholar] [CrossRef]
  67. de Camargo, A.C.; Regitano-d’Arce, M.A.B.; Gallo, C.R.; Shahidi, F. Gamma-irradiation induced changes in microbiological status, phenolic profile and antioxidant activity of peanut skin. J. Funct. Foods 2015, 12, 129–143. [Google Scholar] [CrossRef]
  68. Ayoub, M.; de Camargo, A.C.; Shahidi, F. Antioxidants and bioactivities of free, esterified and insoluble-bound phenolics from berry seed meals. Food Chem. 2016, 197, 221–232. [Google Scholar] [CrossRef]
  69. Rahman, M.J.; de Camargo, A.C.; Shahidi, F. Phenolic and polyphenolic profiles of chia seeds and their in vitro biological activities. J. Funct. Foods 2017, 35, 622–634. [Google Scholar] [CrossRef]
  70. Frazier, R.A.; Deaville, E.R.; Green, R.J.; Stringano, E.; Willoughby, I.; Plant, J.; Mueller-Harvey, I. Interactions of tea tannins and condensed tannins with proteins. J. Pharm. Biomed. Anal. 2010, 51, 490–495. [Google Scholar] [CrossRef]
  71. Hsu, C.-Y.; Lin, G.-M.; Lin, H.-Y.; Chang, S.-T. Characteristics of proanthocyanidins in leaves of Chamaecyparis obtusa var formosana as strong α-glucosidase inhibitors. J. Sci. Food Agric. 2018, 98, 3806–3814. [Google Scholar]
  72. de Camargo, A.C.; da Silva Lima, R. A perspective on phenolic compounds, their potential health benefits, and international regulations: The revised Brazilian normative on food supplements. J. Food Bioact. 2019, 7, 7–17. [Google Scholar] [CrossRef] [Green Version]
  73. Brigatto Fontes, L.C.; Ferraz da Silva Torres, A.E.; Yonekura, L. Optimization of the extraction of antioxidants from guarana (Paullinia cupana) and grape (Vitis labrusca var. Izabel) pomace using response surface methodology. African J. Food Sci. Technol. 2014, 5, 53–59. [Google Scholar]
  74. Gonzales, G.B.; Smagghe, G.; Raes, K.; Van Camp, J. Combined alkaline hydrolysis and ultrasound-assisted extraction for the release of nonextractable phenolics from cauliflower (Brassica oleracea var. botrytis) waste. J. Agric. Food Chem. 2014, 62, 3371–3376. [Google Scholar] [CrossRef] [PubMed]
  75. Singleton, V.L.; Rossi, J.A. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 1965, 16, 144–158. [Google Scholar]
  76. Shahidi, F.; de Camargo, A.C. JFB–Trends in food bioactives. J. Food Bioact. 2019, 8, 2–5. [Google Scholar] [CrossRef]
Sample Availability: Samples of the guarana powder, SPP fraction and IBPP fraction are available from the authors.
Figure 1. Dose-response curves of the inhibitory activity of (A) the soluble polyphenols (SPP) fraction and (B) the insoluble-bound polyphenols (IBPP) fraction on alpha-glucosidase.
Figure 1. Dose-response curves of the inhibitory activity of (A) the soluble polyphenols (SPP) fraction and (B) the insoluble-bound polyphenols (IBPP) fraction on alpha-glucosidase.
Molecules 25 00679 g001
Figure 2. Reaction progress curve in the absence of inhibitors, and in the presence of SPP or IBPP as an inhibitor.
Figure 2. Reaction progress curve in the absence of inhibitors, and in the presence of SPP or IBPP as an inhibitor.
Molecules 25 00679 g002
Figure 3. Enzyme kinetics analysis of both polyphenol fractions on alpha-glucosidase. (A) Lineweaver–Burk plot of the SPP fraction. (B) Lineweaver–Burk plot of the IBPP fraction.
Figure 3. Enzyme kinetics analysis of both polyphenol fractions on alpha-glucosidase. (A) Lineweaver–Burk plot of the SPP fraction. (B) Lineweaver–Burk plot of the IBPP fraction.
Molecules 25 00679 g003
Figure 4. MALDI-TOF spectra of the insoluble-bound polyphenol from guarana powder. (A) 200–1400 Da. 1: Monomers peaks cluster; 2: Dimers peaks cluster; 3: Trimer peaks cluster; 4: Tetramer peaks cluster. (B) 700–4700 Da. 5: Pentamers peaks cluster.
Figure 4. MALDI-TOF spectra of the insoluble-bound polyphenol from guarana powder. (A) 200–1400 Da. 1: Monomers peaks cluster; 2: Dimers peaks cluster; 3: Trimer peaks cluster; 4: Tetramer peaks cluster. (B) 700–4700 Da. 5: Pentamers peaks cluster.
Molecules 25 00679 g004
Figure 5. Simplified chemical structures of proanthocyanidin monomers and representation of the type-A and type-B linkages.
Figure 5. Simplified chemical structures of proanthocyanidin monomers and representation of the type-A and type-B linkages.
Molecules 25 00679 g005
Figure 6. MALDI-TOF spectra of the insoluble-bound polyphenol from guarana powder: inset of the spectra highlighting the 16 Da increments associated with varying degrees of hydroxylation.
Figure 6. MALDI-TOF spectra of the insoluble-bound polyphenol from guarana powder: inset of the spectra highlighting the 16 Da increments associated with varying degrees of hydroxylation.
Molecules 25 00679 g006
Table 1. Calculated inhibition kinetics parameters for the soluble (SPP) and the insoluble-bound polyphenol (IBPP) fractions from guarana powder (Paullinia cupana) on alpha-glucosidase.
Table 1. Calculated inhibition kinetics parameters for the soluble (SPP) and the insoluble-bound polyphenol (IBPP) fractions from guarana powder (Paullinia cupana) on alpha-glucosidase.
Km
(mM)
Vmax
(OD/min)
KI
(µg/mL)
K’I
(µg/mL)
K’I/KIInhibition Mode
No inhibitor0.1280.020////
SPP0.4890.0030.4031.7354.30Mixed
IBPP0.2920.0070.2870.8472.95Mixed
Table 2. Insoluble-bound proanthocyanidin composition from guarana powder (Paullinia cupana) a.
Table 2. Insoluble-bound proanthocyanidin composition from guarana powder (Paullinia cupana) a.
Calculated
[M + H]+
Observed
[M + H]+
Possible Identity
Dimers544.136545.013Type-A afzelechin dimer
560.131560.993Type-A afzelechin/catechin dimer
576.126576.969Type-A catechin dimer
Trimers814.188815.082Type-A afzelechin trimer
830.183831.052Type-A (2)afzelechin/catechin trimer
846.178847.021Type-A afzelechin/(2)catechin
862.173862.995Type-A catechin trimer
Tetramers1090.2881089.061Type-B afzelechin tetramer
1106.2831105.044Type-B (3)afzelechin/catechin tetramer
1122.2781121.009Type-B (2)afzelechin/(2)catechin tetramer
1116.2301117.052Type-A (2)afzelechin/(2)catechin tetramer
1132.2251133.023Type-A afzelechin/(3)catechin tetramer
1148.2201148.998Type-A catechin tetramer
1164.2151164.962Type-A (3)catechin/gallocatechin tetramer
a: Selected peaks of the IBPP fraction obtained with MALDI-TOF.

Share and Cite

MDPI and ACS Style

Pinaffi, A.C.d.C.; Sampaio, G.R.; Soares, M.J.; Shahidi, F.; de Camargo, A.C.; Torres, E.A.F.S. Insoluble-Bound Polyphenols Released from Guarana Powder: Inhibition of Alpha-Glucosidase and Proanthocyanidin Profile. Molecules 2020, 25, 679. https://doi.org/10.3390/molecules25030679

AMA Style

Pinaffi ACdC, Sampaio GR, Soares MJ, Shahidi F, de Camargo AC, Torres EAFS. Insoluble-Bound Polyphenols Released from Guarana Powder: Inhibition of Alpha-Glucosidase and Proanthocyanidin Profile. Molecules. 2020; 25(3):679. https://doi.org/10.3390/molecules25030679

Chicago/Turabian Style

Pinaffi, Ana Clara da Costa, Geni Rodrigues Sampaio, Maiara Jurema Soares, Fereidoon Shahidi, Adriano Costa de Camargo, and Elizabeth A. F. S. Torres. 2020. "Insoluble-Bound Polyphenols Released from Guarana Powder: Inhibition of Alpha-Glucosidase and Proanthocyanidin Profile" Molecules 25, no. 3: 679. https://doi.org/10.3390/molecules25030679

Article Metrics

Back to TopTop